Ulcer

The chart shows the growth of an initial investment of $10,000 in Ulcer, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced Every 3 months.

Based on dividend-adjusted daily data since Aug 20, 2025, Ulcer's average daily return is +0.25%, while the average monthly return is +4.89%. At this rate, an investment would double in approximately 1.2 years.

Historically, 82% of months were positive and 18% were negative. The best month was Apr 2026 with a return of +17.5%, while the worst month was Mar 2026 at -5.5%. The longest winning streak lasted 3 consecutive months, and the longest losing streak was 1 months.

On a daily basis, Ulcer closed higher 61% of trading days. The best single day was Apr 8, 2026 with a return of +4.6%, while the worst single day was Jun 5, 2026 at -5.9%.

Ulcer has an annualized alpha of 44.80%, beta of 1.51, and R2 of 0.72 versus S&P 500 Index. Calculated based on daily prices since August 20, 2025.

• This portfolio captured 254.33% of S&P 500 Index gains and tended to rise during its downturns (downside capture of -54.96%) - a profile typical of hedging or uncorrelated assets.
• This portfolio generated an annualized alpha of 44.80% versus S&P 500 Index - delivering returns beyond what market exposure alone would predict.
• Beta of 1.51 means this portfolio moves significantly more than S&P 500 Index - expect amplified gains in rallies and amplified losses in downturns.

Ulcer has an expense ratio of 0.36%, placing it in the medium range. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.

There isn't enough data available to calculate the Sharpe ratio for Ulcer. This metric is based on the past 12 months of trading data. Please check back later for updated information.

Ulcer provided a 0.67% dividend yield over the last twelve months.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Ulcer. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Ulcer was 9.63%, occurring on Mar 30, 2026. Recovery took 6 trading sessions.

The current Ulcer drawdown is 4.53%.

The chart below shows the rolling one-month volatility.